Insider · CIK 0001726533

O'Grady Brendan P.

Reports to the SEC for 3 companies · TEL-AVIV-YAFO

sec.gov

Transactions

Companies

Filings

CIK

0001726533

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-31	ASRTAssertio Holdings, Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+167K sh	—	—	178,371.462
2025-05-31	ASRTAssertio Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO	MExercise/Conversion	−167K sh	—	—	333,335
2025-05-31	ASRTAssertio Holdings, Inc.F Tax Payment	Director, CEO	FTax Payment	−49.4K sh	$0.66	−$32.8K	128,955.462
2025-02-18	ASRTAssertio Holdings, Inc. · Restricted Stock UnitsA Award	Director, CEO	AAward	+500K sh	—	—	500,000
2025-02-18	ASRTAssertio Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+756K sh	—	—	755,525
2024-05-31	ASRTAssertio Holdings, Inc. · Restricted Stock UnitsA Award	Director, CEO	AAward	+500K sh	—	—	500,000
2024-05-31	ASRTAssertio Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+1.8M sh	—	—	1,800,000
2021-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+109K sh	—	—	109,315
2021-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−11.4K sh	$10.54	−$121K	14,868.486
2021-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−703 sh	$10.80	−$7,592.4	14,868.486
2021-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+18.9K sh	—	—	33,773.486
2021-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−7,469 sh	$10.57	−$78.9K	26,304.486
2021-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−18.9K sh	—	—	37,811
2021-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,166 sh	—	—	16,034.486
2021-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−463 sh	$10.86	−$5,029.384	15,571.486
2021-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,166 sh	—	—	0
2021-03-02	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−15.1K sh	$10.85	−$164K	14,868.486
2021-03-01	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−63.3K sh	$10.93	−$691K	29,953.486
2021-03-01	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−9,849 sh	$10.83	−$107K	93,231.486
2021-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−24.9K sh	—	—	74,805
2021-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+24.9K sh	—	—	103,080.486
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−16.7K sh	$12.69	−$212K	78,146.486
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−3,974 sh	$12.69	−$50.4K	94,866.486
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDA Award	EVP, North America Commercial	AAward	+67.9K sh	—	—	98,840.486
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+16.1K sh	—	—	30,988.486
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−16.1K sh	—	—	16,121
2020-03-17	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,179 sh	—	—	15,338.486
2020-03-17	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−470 sh	$7.16	−$3,366.845	14,868.486
2020-03-17	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,179 sh	—	—	0
2020-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,166 sh	—	—	1,166
2020-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−463 sh	$11.37	−$5,262.365	14,159.486
2020-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,166 sh	—	—	14,622.486
2020-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+99.7K sh	—	—	99,739
2020-02-10	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−4,799 sh	$12.27	−$58.9K	13,456.486
2020-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−16.1K sh	—	—	32,241
2020-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+16.1K sh	—	—	18,255.486
2019-09-18	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,241 sh	—	—	0
2019-09-18	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,241 sh	—	—	2,629.486
2019-09-18	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−494 sh	$7.83	−$3,868.662	2,135.486
2019-03-18	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−1,179 sh	$16.63	−$19.6K	1,388.486
2019-03-17	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,179 sh	—	—	1,179
2019-03-17	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,179 sh	—	—	2,567.486
2019-03-12	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−738 sh	—	—	0
2019-03-12	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+738 sh	—	—	2,126.486
2019-03-12	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−738 sh	$15.67	−$11.6K	1,388.486
2019-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+56.7K sh	—	—	56,716
2019-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−1,166 sh	$16.88	−$19.7K	1,388.486
2019-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,166 sh	—	—	2,332
2019-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,166 sh	—	—	2,554.486
2018-09-18	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,241 sh	—	—	2,629.486

Recent filings

Accepted (ET)
Jun 34
O'Grady Brendan P.0001104659-25-056049
SEC(opens sec.gov)
Feb 204
O'Grady Brendan P.0001104659-25-015756
SEC(opens sec.gov)
Jun 44
O'Grady Brendan P.0001104659-24-068356
SEC(opens sec.gov)
Mar 84
O'Grady Brendan P.0001209191-21-018526
SEC(opens sec.gov)
Mar 44
O'Grady Brendan P.0001209191-21-017764
SEC(opens sec.gov)
Mar 24
O'Grady Brendan P.0001209191-21-015852
SEC(opens sec.gov)

Companies

Address

P.O. BOX 284

TEL-AVIV-YAFO, 6100201